Bromide

Bromide

SCHEMBL8085949

Br.O=C(O)CNCCCc1cc(Cl)cc2[nH]c(=O)c(=O)[nH]c12

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
GRIN2A known ✓ Q12879 6/20 0.49
GRIN1 Q05586 7/20 0.49
GRIN2D O15399 6/20 0.49
GRIN3B O60391 6/20 0.49
GRIN2B Q13224 6/20 0.49
GRIN2C Q14957 6/20 0.49
GRIN3A Q8TCU5 6/20 0.49
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
GAA P10253 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8090392 0.76 GRIN1 (0.58) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL8619216 0.73 GRIN1 (0.70) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL8090253 0.72
SCHEMBL8615504 0.72 GRIN1 (0.68) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL17594492 0.71 HIF1A (0.47) KDM4EHSD17B10
SCHEMBL8620550 0.70 GRIN1 (0.74) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL8086902 0.68 GRIN1 (0.55) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
Phosphonic Acid SCHEMBL27488531 0.67 GRIN1 (0.53) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
Phosphonic Acid SCHEMBL27504235 0.66 GRIN1 (0.60) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
Bromide SCHEMBL8087243 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0853617-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES Novartis AG (CH) 1998-07-22 EP claimed
WO-1997008155-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES NOVARTIS AG (CH) 1997-03-06 WO claimed
US-6080743-A AS CHEMICAL INTERMEIDATES FOR PREPARING DRUGS NOVARTIS AG (CH) 2000-06-27 US disclosed